Indiana Pacers forward Caris LeVert's availability to play is now uncertain after an MRI revealed a small mass on his kidney, the team announced on Saturday.

The Pacers said LeVert would undergo further testing and updates would be provided.

The ailment was discovered during the physical Caris LeVert had to undergo in order to finalize the four-team blockbuster that sent James Harden to the Brooklyn Nets. LeVert was dealt from Brooklyn to the Houston Rockets, then flipped for guard Victor Oladipo

The fifth-year wing released a statement thanking the organization for its support.

“On behalf of my family and myself, we want to thank the Indiana Pacers for their support and guidance. We are grateful for their extreme thoroughness during the physical process and I am looking forward to joining the team and being part of this great organization as soon as possible.”

Because of the hiccup in the physical, the Pacers received a bonus second-round pick and cash from the Nets.

Pacers president of basketball organization Kevin Pritchard also commented on LeVert's diagnosis.

“We acquired Caris because of who he is as a young man first and foremost. His basketball skill and on court play speaks for itself and we know he has a great career ahead of him. We will support Caris through this time and know that he will join us on the court as soon as he is able.”

In four-plus seasons with the Nets, the 26-year-old averaged 13.1 points per game. He saw an increasingly bigger role during the 2019-20 season as Kevin Durant nursed an Achilles injury, putting up 18.7 points per game.

Before this week's trade, LeVert had carved out a nice role as a productive point-forward sixth man, averaging 18.5 points and 6.0 assists in 27.8 minutes per game, coming off the bench in eight of 12 games.

LeVert signed a three-year, $52.5 million contract extension in August 2019.

Best wishes to Caris.